Atlas Trials

Separation Surgery Followed by Stereotactic Ablative Body Radiotherapy (SABR) Versus SABR Alone for Spinal Metastases

Clinical trial NCT06613295 · RECRUITING

Trial details

NCT number
NCT06613295
Sponsor
Cancer Research Antwerp
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Solid TumorSpinal NeoplasmsSpinal Tumor
Start date
2022-03-07
Primary completion
2025-03-01
Enrollment
128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.